Showing 59,901 - 59,920 results of 113,932 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.12s Refine Results
  1. 59901

    Data_Sheet_1_Sub-seasonal to seasonal drivers of dry extreme rainfall events over Northeast Thailand.pdf by Abayomi A. Abatan (11522473)

    Published 2023
    “…Five models out of the 19 examined capture the observed pattern during BSISO phases 4 and 5, while only three models capture the BSISO phase 3 behavior. …”
  2. 59902

    Is Increasing Doses of Imazapyr + Imazapic Detrimental to the Main Crop Rotation Alternatives to Flooded Rice? by A.R. ULGUIM (6572777)

    Published 2019
    “…In the first crop season, flooded rice was cultivated using herbicide rates in order to have levels of residue in the soil: 0, 140 (label dosage, equivalent to 73.5+24.5 g a.i. ha-1), 280, 560, 840 and 1,120 g ha-1. …”
  3. 59903

    The effect of Se-source, Se-dosage, and foot rot status on whole-blood Se concentrations in sheep. by Jean A. Hall (289030)

    Published 2013
    “…<p>Whole-blood Se concentrations were measured after 0, 14, 27, 40, and 54 wk of Se supplementation, and foot rot severity was assessed after 0, 20, 28, 40, and 60 wk of Se supplementation in ewes receiving no Se treatment, Na-selenate at a dosage rate of 8.95 mg Se/wk per ewe, or Na-selenite and Se-Yeast at 4.9, 14.7, or 24.5 mg Se/wk per ewe for 62 wk. …”
  4. 59904

    The effect of Se-source, Se-dosage, and foot rot status on serum-Se concentrations in sheep. by Jean A. Hall (289030)

    Published 2013
    “…<p>Serum-Se concentrations were measured after 0, 14, 27, 40, and 54 wk of Se supplementation, and foot rot severity was assessed after 0, 20, 28, 40, and 60 wk of Se supplementation in ewes receiving no Se treatment, Na-selenate at a dosage rate of 8.95 mg Se/wk per ewe, or Na-selenite and Se-Yeast at 4.9, 14.7, or 24.5 mg Se/wk per ewe for 62 wk. …”
  5. 59905

    Supplementary Material for: The role of transbronchial cryobiopsy in the detection of pulmonary GvHD. by Sadowska-Klasa A. (20361480)

    Published 2024
    “…Pulmonary GvHD was confirmed by cryoTBB histopathology in 5 of 11 (45%) cases. Immunosuppression was either stopped or decreased in 6 patients with negative results for GvHD with further clinical improvement. …”
  6. 59906

    The effect of Glucagon-Like Peptide-1 Receptor Blockade on glucagon-induced stimulation of insulin secretion by Rahele A. Farahani (14285131)

    Published 2022
    “…In the first experiment, during a hyperglycemic clamp, glucagon was infused at 0.4ng/kg/min, increasing by 0.2ng/kg/min every hour for 5 hours. …”
  7. 59907

    TH phosphorylation evoked by HDZ (10 mg/kg i.p., n = 6) or 2DG (400 by Hanafi A. Damanhuri (296714)

    Published 2013
    “…<p> <b>mg/kg i.p., n = 5) compared to saline (i.p. n = 5) in the A6 region.…”
  8. 59908

    Data Sheet 1_Association between antibiotic usage during infancy and asthma incidence among children: a population-level ecological study in British Columbia, Canada.docx by Abdullah Al Mamun (440528)

    Published 2024
    “…During 2000–2014, adjusted incidence risk ratio (aIRR) for children under Quintile 5 of average antibiotic prescribing was 1.75 (95% CI: 1.63–1.88, P < 0.0001) times higher than that for Quintile 1. …”
  9. 59909

    Supplementary Material for: Calcium-citrate anticoagulation during continuous renal replacement therapy in patients with metformin intoxication: a case series, mathematical estimat... by Brunoni B. (16876404)

    Published 2023
    “…The T/I calcium ratio was consistently below 2.5, and SIG decreased, reaching values lower than 6 mEq/L after 48h of CVVH treatment. …”
  10. 59910

    Data_Sheet_1_The Persister Character of Clinical Isolates of Staphylococcus aureus Contributes to Faster Evolution to Resistance and Higher Survival in THP-1 Monocytes: A Study Wit... by Tiep K. Nguyen (9671153)

    Published 2020
    “…Evolution to resistance (moxifloxacin MIC ≥ 0.5 mg/L) was triggered by serial passages at 0.5× MIC (with daily concentration readjustments). …”
  11. 59911
  12. 59912

    Table_1_Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover study.DOCX by Helena Zander Wodschow (14589455)

    Published 2023
    “…</p>Results<p>We included 12 participants previously hospitalized for COVID-19 with a mean (±SD) age of 60 ± 10 years. The mean time from hospitalization was 18 ± 5 months. …”
  13. 59913

    Image_2_Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover study.JPEG by Helena Zander Wodschow (14589455)

    Published 2023
    “…</p>Results<p>We included 12 participants previously hospitalized for COVID-19 with a mean (±SD) age of 60 ± 10 years. The mean time from hospitalization was 18 ± 5 months. …”
  14. 59914

    Image_1_Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover study.JPEG by Helena Zander Wodschow (14589455)

    Published 2023
    “…</p>Results<p>We included 12 participants previously hospitalized for COVID-19 with a mean (±SD) age of 60 ± 10 years. The mean time from hospitalization was 18 ± 5 months. …”
  15. 59915

    DataSheet_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.xlsx by Joel A. Pogue (14597114)

    Published 2023
    “…Compared to the Eclipse generated plans, the proposed Ethos template generated plans with greater evaluation planning target volume (PTV_Eval) V100% coverage (p = 0.01), significantly decreased heart V1.5Gy (p< 0.001), and increased contralateral breast V5Gy, skin D0.01cc, and RTOG conformity index (p = 0.03, p = 0.03, and p = 0.01, respectively). …”
  16. 59916

    DataSheet1_Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.docx by Mohamed A. Kamal (9654559)

    Published 2024
    “…</p>Results<p>Treatment-emergent ADAs were observed in up to 8.6% (aged ≥18 years), 16.0% (12-17 years), 5.3% (6-11 years), and 2.0% (6 months to 5 years) dupilumab-treated patients. …”
  17. 59917

    Video1_Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.mp4 by Mohamed A. Kamal (9654559)

    Published 2024
    “…</p>Results<p>Treatment-emergent ADAs were observed in up to 8.6% (aged ≥18 years), 16.0% (12-17 years), 5.3% (6-11 years), and 2.0% (6 months to 5 years) dupilumab-treated patients. …”
  18. 59918

    Table_1_Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning.docx by Joel A. Pogue (14597114)

    Published 2023
    “…Compared to the Eclipse generated plans, the proposed Ethos template generated plans with greater evaluation planning target volume (PTV_Eval) V100% coverage (p = 0.01), significantly decreased heart V1.5Gy (p< 0.001), and increased contralateral breast V5Gy, skin D0.01cc, and RTOG conformity index (p = 0.03, p = 0.03, and p = 0.01, respectively). …”
  19. 59919

    Evolution of provirus environment during primary infection. by Nicolas A. Gillet (207517)

    Published 2013
    “…Gene and CpG proximity was calculated with a genomic interval of 50-values are calculated by Chi-squared test for trend and show significance of the increasing or decreasing trend from the seroconversion date to day 68 post-inoculation. …”
  20. 59920

    Data_Sheet_1_Additive Effects of Obesity on Myocardial Microcirculation and Left Ventricular Deformation in Essential Hypertension: A Contrast-Enhanced Cardiac Magnetic Resonance I... by Pei-Lun Han (12283394)

    Published 2022
    “…</p>Methods<p>This study comprised 101 hypertensive patients, including 54 subjects with a body mass index (BMI) of 18.5–24.9 kg/m<sup>2</sup> and 47 subjects with a BMI ≥25 kg/m<sup>2</sup>, as well as 55 age- and sex-matched controls with a BMI of 18.5–24.9 kg/m<sup>2</sup>. …”